February JAAD: A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients episode artwork

EPISODE · Feb 7, 2022

February JAAD: A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients

from AAD's Dialogues in Dermatology

Anne Lynn Su Chang, MD interviewed by Vesna Petronic-Rosic, MD, FAAD

Episode metadata supplied by the publisher feed · Published Feb 7, 2022

Embed this episode

Ready to play

February JAAD: A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients

0:00 0:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

When was this AAD's Dialogues in Dermatology episode published?

This episode was published on February 7, 2022.

Can I download this AAD's Dialogues in Dermatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!